Why Moderna Stock Jumped Over 20% This Week
Shares of (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market Intelligence.
The maker of vaccines, including the mRNA vaccine for COVID-19, is amid a 90% stock price downturn. In fact, the share price is now only right around the same level as it was before the 2020 pandemic. However, this week, the company got good news with a mention of mRNA vaccines at the Project Stargate announcement and a new contract with the European Union.
As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.
Source Fool.com
Moderna Inc. Stock
€25.88
1.730%
Based on 9 Buy predictions and 10 Sell predictions the sentiment towards Moderna Inc. is rather balanced.
With a target price of 22 € there is a slightly negative potential of -14.99% for Moderna Inc. compared to the current price of 25.88 €.
